These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23958960)

  • 41. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
    Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
    Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.
    Kuwabara H; Heishman SJ; Brasic JR; Contoreggi C; Cascella N; Mackowick KM; Taylor R; Rousset O; Willis W; Huestis MA; Concheiro M; Wand G; Wong DF; Volkow ND
    PLoS One; 2014; 9(12):e113694. PubMed ID: 25493427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray.
    Torres-Reverón A; Palermo K; Hernández-López A; Hernández S; Cruz ML; Thompson KJ; Flores I; Appleyard CB
    Reprod Sci; 2016 Sep; 23(9):1158-67. PubMed ID: 27089914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placebo effects on human mu-opioid activity during pain.
    Wager TD; Scott DJ; Zubieta JK
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mu opioid receptor localization in the basolateral amygdala: An ultrastructural analysis.
    Zhang J; Muller JF; McDonald AJ
    Neuroscience; 2015 Sep; 303():352-63. PubMed ID: 26164501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aerobic Fitness Is Associated with Cerebral μ-Opioid Receptor Activation in Healthy Humans.
    Saanijoki T; Kantonen T; Pekkarinen L; Kalliokoski K; Hirvonen J; Malén T; Tuominen L; Tuulari JJ; Arponen E; Nuutila P; Nummenmaa L
    Med Sci Sports Exerc; 2022 Jul; 54(7):1076-1084. PubMed ID: 35195103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Social touch modulates endogenous μ-opioid system activity in humans.
    Nummenmaa L; Tuominen L; Dunbar R; Hirvonen J; Manninen S; Arponen E; Machin A; Hari R; Jääskeläinen IP; Sams M
    Neuroimage; 2016 Sep; 138():242-247. PubMed ID: 27238727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
    David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
    Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.
    Tuominen L; Nummenmaa L; Keltikangas-Järvinen L; Raitakari O; Hietala J
    Hum Brain Mapp; 2014 May; 35(5):1875-84. PubMed ID: 23671038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opioidergic Regulation of Emotional Arousal: A Combined PET-fMRI Study.
    Karjalainen T; Seppälä K; Glerean E; Karlsson HK; Lahnakoski JM; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L
    Cereb Cortex; 2019 Aug; 29(9):4006-4016. PubMed ID: 30475982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.
    Rodríguez-Muñoz M; Sánchez-Blázquez P; Vicente-Sánchez A; Berrocoso E; Garzón J
    Neuropsychopharmacology; 2012 Jan; 37(2):338-49. PubMed ID: 21814188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
    Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
    J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reaching out for Sensitive Evaluation of the Mu Opioid Receptor in Vivo: Positron Emission Tomography Imaging of the Agonist [
    Rafique W; Khanapur S; Spilhaug MM; Riss PJ
    ACS Chem Neurosci; 2017 Sep; 8(9):1847-1852. PubMed ID: 28590714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
    Tershner SA; Helmstetter FJ
    Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mu opioid receptors in GABAergic neurons of the forebrain promote alcohol reward and drinking.
    Ben Hamida S; Boulos LJ; McNicholas M; Charbogne P; Kieffer BL
    Addict Biol; 2019 Jan; 24(1):28-39. PubMed ID: 29094432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.
    Turton S; Myers JF; Mick I; Colasanti A; Venkataraman A; Durant C; Waldman A; Brailsford A; Parkin MC; Dawe G; Rabiner EA; Gunn RN; Lightman SL; Nutt DJ; Lingford-Hughes A
    Mol Psychiatry; 2020 Aug; 25(8):1749-1758. PubMed ID: 29942043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-
    Puig S; Barker KE; Szott SR; Kann PT; Morris JS; Gutstein HB
    Mol Pharmacol; 2020 Oct; 98(4):487-496. PubMed ID: 32723769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.